BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36346310)

  • 1. Characteristics of CD8
    Lu X; Song B; Weng W; Su B; Wu H; Cheung AKL; Zhang T; Gao Y
    Viral Immunol; 2023 Jan; 36(1):25-32. PubMed ID: 36346310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.
    Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
    Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
    Front Immunol; 2019; 10():1926. PubMed ID: 31456810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
    Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
    J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
    Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
    J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4
    Ponnan SM; Vidyavijayan KK; Thiruvengadam K; Hilda J N; Mathayan M; Murugavel KG; Hanna LE
    Front Immunol; 2021; 12():666388. PubMed ID: 33936106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.
    Burchill MA; Golden-Mason L; Wind-Rotolo M; Rosen HR
    J Viral Hepat; 2015 Dec; 22(12):983-91. PubMed ID: 26482547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Lu X; Song B; Weng W; Xia H; Su B; Wu H; Zhang T; Li W; Gao Y
    Viral Immunol; 2017 Nov; 30(9):642-648. PubMed ID: 29035156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signatures of protective memory immune responses during hepatitis C virus reinfection.
    Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
    Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients.
    Shen T; Zheng J; Xu C; Liu J; Zhang W; Lu F; Zhuang H
    Virol J; 2010 Nov; 7():310. PubMed ID: 21070674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
    Zhuang Y; Wei X; Li Y; Zhao K; Zhang J; Kang W; Sun Y
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
    Telatin V; Nicoli F; Frasson C; Menegotto N; Barbaro F; Castelli E; Erne E; Palù G; Caputo A
    Front Cell Infect Microbiol; 2019; 9():190. PubMed ID: 31259160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.
    Munusamy Ponnan S; Hayes P; Fernandez N; Thiruvengadam K; Pattabiram S; Nesakumar M; Srinivasan A; Kathirvel S; Shankar J; Goyal R; Singla N; Mukherjee J; Chatrath S; Gilmour J; Subramanyam S; Prasad Tripathy S; Swaminathan S; Hanna LE
    PLoS One; 2020; 15(2):e0229461. PubMed ID: 32097435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral PD-1
    Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
    Front Immunol; 2019; 10():1470. PubMed ID: 31316516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.